Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

Biology of Blood and Marrow Transplantation

Volumn 9, Issue 8, 2003, Pages 505-511

  Ratanatharathorn, Voravit ^a,b   Ayash, Lois ^a   Reynolds, Christopher ^a   Silver, Samuel ^a   Reddy, Pavan ^a   Becker, Michael ^a   Ferrara, James L M ^a   Uberti, Joseph P ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b Cancer Center   (United States)

Author keywords

Acute graft versus host disease; Allogeneic transplantation; Anti CD20 antibody; B cell depletion; Chronic graft versus host disease; Hematopoietic stem cell transplantation

Indexed keywords

BUSULFAN; CARMUSTINE; CD20 ANTIBODY; CHIMERIC ANTIBODY; COLD AGGLUTININ; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; ETRETIN; FLUDARABINE; HYDROCORTISONE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; SALBUTAMOL; STEROID; TACROLIMUS; THALIDOMIDE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CHRONIC GRAFT REJECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENERAL CONDITION IMPROVEMENT; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; MALE; MEMBRANOUS GLOMERULONEPHRITIS; OUTCOMES RESEARCH; PATHOGENESIS; PUVA; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; REVIEW; XEROPHTHALMIA;

EID: 1542472753     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(03)00216-7     Document Type: Article

References (33)

1. Arora M. Wagner J.E. Davies S.M. et al. Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease Biol Blood Marrow Transplant 7 2001 265-273
2. Koc S. Leisenring W. Flowers M.E. et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone Blood 100 2002 48-51
3. Ratanatharathorn V. Ayash L. Lazarus H.M. Fu J. Uberti J.P. Chronic graft-versus-host disease: clinical manifestation and therapy Bone Marrow Transplant 28 2001 121-129
4. Yu X. Carpenter P. Anasetti C. Advances in transplantation tolerance Lancet 357 2001 1959-1963
5. Ratanatharathorn V. Carson E. Reynolds C. et al. Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease Ann Intern Med 133 2000 275-279
6. Lipsky P.E. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity Nat Immunol 2 2001 764-766
7. Murphy W.J. Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes J Clin Invest 106 2000 745-747
8. Shustov A. Luzina I. Nguyen P. et al. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity J Clin Invest 106 2000 R39-R47
9. McLaughlin P. Grillo-Lopez A.J. Link B.K. et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program J Clin Oncol 16 1998 2825-2833
10. Looney R.J. Treating human autoimmune disease by depleting B cells Ann Rheum Dis 61 2002 863-866
11. Stasi R. Pagano A. Stipa E. Amadori S. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura Blood 98 2001 952-957
12. Levine T.D. Pestronk A. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab Neurology 52 1999 1701-1704
13. Morselli M. Luppi M. Potenza L. et al. Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment Blood 99 2002 3478-3479
14. Ahrens N. Kingreen D. Seltsam A. Salama A. Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab) Br J Haematol 114 2001 244-245
15. Zecca M. De Stefano P. Nobili B. Locatelli F. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia Blood 97 2001 3995-3997
16. Specks U. Fervenza F.C. McDonald T.J. Hogan M.C. Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy Arthritis Rheum 44 2001 2836-2840
17. Remuzzi G. Chiurchiu C. Abbate M. Brusegan V. Bontempelli M. Ruggenenti P. Rituximab for idiopathic membranous nephropathy Lancet 360 2002 923-924
18. Leandro M.J. Edwards J.C. Cambridge G.Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion Ann Rheum Dis 61 2002 883-888
19. Zaja F. Russo D. Fuga G. Perella G. Baccarani M. Rituximab for myasthenia gravis developing after bone marrow transplant Neurology 55 2000 1062-1063
20. Ship A. May W. Lucas K. Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantation Bone Marrow Transplant 29 2002 365-366
21. Vogelsang G.B. Farmer E.R. Hess A.D. et al. Thalidomide for the treatment of chronic graft-versus-host disease N Engl J Med 326 1992 1055-1058
22. Parker P.M. Chao N. Nademanee A. et al. Thalidomide as salvage therapy for chronic graft-versus-host disease Blood 86 1995 3604-3609
23. Koc S. Leisenring W. Flowers M.E. et al. Thalidomide for treatment of patients with chronic graft-versus-host disease Blood 96 2000 3995-3996
24. Dall'Amico R. Messina C. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease Ther Apher 6 2002 296-304
25. Greinix H.T. Volc-Platzer B. Kalhs P. et al. Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study Blood 96 2000 2426-2431
26. Stasi R. Stipa E. Forte V. Meo P. Amadori S. Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura Blood 99 2002 3872-3873
27. Clements P.J. Systemic sclerosis (scleroderma) and related disorders: clinical aspects Baillieres Best Pract Res Clin Rheumatol 14 2000 1-16
28. Tayebi H. Lapierre V. Saas P. et al. Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graft Br J Haematol 114 2001 698-700
29. Biedermann B.C. Sahner S. Gregor M. et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease Lancet 359 2002 2078-2083
30. Dustin M.L. Dustin L.B. The immunological relay race: B cells take antigen by synapse Nat Immunol 2 2001 480-482
31. Batista F.D. Iber D. Neuberger M.S. B cells acquire antigen from target cells after synapse formation Nature 411 2001 489-494
32. Szabolcs P.R. Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease Bone Marrow Transplant 30 2002 327-329
33. Miklos D.B. Kim H.T. Zorn E. et al. Antibody response to H-Y minorhistocompatibility antigen DBY is detected in male patients after allogeneic stem cell transplantation and in normal female donors Blood 100 2003 213a-214a